The U.S. ION® Endoluminal Territory Associate plays a critical role in the early adoption of the Ion® platform in expanding access to minimally invasive care for lung biopsy. This individual will be primarily focused on supporting early sustainable users and programs and the development of KOL’s and programs that can highlight the early clinical, economic and strategic value of ION®.